Miller A B
Department of Preventive Medicine and Biostatistics, University of Toronto.
Can Fam Physician. 1993 Jan;39:85-90.
The role of mammography as a screening test for breast cancer is still being evaluated. Screening does not seem to reduce breast cancer mortality in women age 40 to 49. However, for women age 50 to 69, a 40% reduction in breast cancer mortality can be anticipated after 5 years, providing high compliance to screening is obtained.
乳腺钼靶作为乳腺癌筛查检测手段的作用仍在评估中。筛查似乎并不能降低40至49岁女性的乳腺癌死亡率。然而,对于50至69岁的女性,如果能高度依从筛查,预计5年后乳腺癌死亡率可降低40%。